Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2008; 100(01): 3-4
DOI: 10.1160/TH08-05-0336
DOI: 10.1160/TH08-05-0336
Editorial Focus
Mean platelet volume not so far from being a routine diagnostic and prognostic measurement
Further Information
Publication History
Received
30 May 2008
Accepted
30 May 2008
Publication Date:
22 November 2017 (online)
-
References
- 1 Massberg S, Schulz C, Gawaz M. Role of platelets in the pathophysiology of acute coronary syndrome. Semin Vasc Med 2003; 03: 147-162.
- 2 Martin JF, Bath PMW, Burr ML. Influence of platelet size on outcome after myocardial infarction. Lancet 1991; 338: 1409-1411.
- 3 Bentfield-Barker ME, Bainton DF. Identification of primary lysosomes in human megakaryocytes and platelets. Blood 1982; 59: 472-481.
- 4 Hoffman R. Regulation of megakaryocytopoiesis. Blood 1989; 74: 1196-1212.
- 5 Kaushansky K, Lok S, Holly RD. et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994; 369: 568-571.
- 6 Harker LA, Marzec UM, Hunt P. et al. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates. Blood 1996; 88: 511-521.
- 7 Kojima H, Shinagawa A, Shimizu S. et al. Role of phosphatidylinositol-3 kinase and its association with Gab1 in thrombopoietin-mediated up-regulation of platelet function. Exp Hematol 2001; 29: 616-622.
- 8 Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995; 85: 2720-2730.
- 9 Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 1997; 89: 101-107.
- 10 Wolber EM, Fandrey J, Frackowski U. et al. Hepatic thrombopoietin mRNA is increased in acute inflammation. Thromb Haemost 2001; 86: 1421-1424.
- 11 Brown AS, Hong Y, de Belder A. et al. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 802-807.
- 12 Senaran H, Ileri M, Altinbas A. et al. Thrombopoietin and mean platelet volume in coronary artery disease. Clin Cardiol 2001; 24: 405-408.
- 13 Muscari A, Pascalis SD, Cennil A. et al. Determinants of mean platelet volume (MPV) in an elderly population: Relevance of body fat, blood glucose and ischaemic electrocardiographic changes. Thromb Haemost 2008; 99: 1079-1084.
- 14 Papanas N, Symeonidis G, Maltezos E. et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004; 15: 475-478.
- 15 Coban E, Ozdogan M, Yazicioglu G. et al. The mean platelet volume in patients with obesity. Int J Clin Pract 2005; 59: 981-982.
- 16 Sewell R, Ibbotson RM, Phillips R. et al. High mean platelet volume after myocardial infarction: is it due to consumption of small platelets?. Br Med J 1984; 289: 1576-1578.
- 17 Cesari F, Marcucci R, Caporale R. et al. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy. Thromb Haemost 2008; 99: 930-935.